Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage

Journal of Obstetrics and Gynaecology Research

Volumn 34, Issue SUPPL.1, 2008, Pages 623-630

  Nohira, Tomoyoshi ^a   Osakabe, Yumi ^a   Suda, Shingo ^a   Takahashi, Chie ^a   Tanaka, Asashi ^a   Ikeda, Kazumi ^a   Ikeda, Toshiaki ^a   Okabe, Kazuhiro ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Disseminated intravascular coagulopathy; Hypovolemic shock; Postpartum hemorrhage; Pregnancy; Recombinant activated factor VII

Indexed keywords

CARBAZOCHROME; DOPAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITODRINE; TRANEXAMIC ACID; BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CESAREAN SECTION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; HYPOVOLEMIC SHOCK; HYSTERECTOMY; LABORATORY TEST; OBSTETRIC HEMORRHAGE; PLACENTA ACCRETA; PLACENTA PREVIA; PROTHROMBIN TIME; UTERUS CONTRACTION; BLOOD EXAMINATION; POSTPARTUM HEMORRHAGE; PREGNANCY; ANAMNESIS; DRUG EFFICACY; ERYTHROCYTE CONCENTRATE; GESTATIONAL AGE; HEMATOLOGY; INTENSIVE CARE UNIT; TREATMENT OUTCOME;

ADULT; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR VIIA; FEMALE; HEMATOLOGIC TESTS; HUMANS; PLACENTA ACCRETA; POSTPARTUM HEMORRHAGE; PREGNANCY; RECOMBINANT PROTEINS;

EID: 52649083255     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00896.x     Document Type: Article

References (49)

1. Mother's and Children's Health and Welfare Association. Maternal death and percentages by main cause 1995-2005. In : Mother's and Children's Health and Welfare Association. Maternal and Child Health Statistics of Japan. Tokyo : Health and Welfare Association, 2007 78 80.
2. Bonar J. Massive obstetric haemorrhage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000 14 : 1 18.
3. Jansen AJ, van Rhenen DJ, Steegers EA, Duvekot JJ. Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv 2005 60 : 663 671.
4. Lusher J, Ingerslev J, Roberts H, Hender U. Clinical experience with recombinant factor VIIa. Blood Coagul Fibrinolysis 1998 9 : 119 128.
5. Hender U. Factor VIIa in the treatment of hemophilia. Blood Coagul Fibrinolysis 1990 1 : 307 317.
6. Hunault M, Bauer KA. Recombinant factor VIIa for the treatment of congenital factor VII deficiency. Semin Thromb Hemost 2000 26 : 401 405.
7. van Buuren HR, Wielenga JJ. Successful surgery using recombinant factor VIIa for recurrent idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia. Dig Dis Sci 2002 47 : 2134 2136.
8. Poon MC, d'Oiron R. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group. Blood Coagul Fibrinolysis 2000 11 (Suppl 1 S55 S68.
9. Uhlmann EJ, Eby CS. Recombinant activated factor VII for non-hemophiliac bleeding patients. Curr Opin Hematol 2004 11 : 198 204.
10. Goodnough LT, Lubin DM, Zhang L, Desposits G, Eby C. Transfusion medicine service policies for recombinant factor VIIa administration. Transfusion 2004 44 : 1325 1331.
11. Ghorshian S, Hunt BJ. Off-license' use of recombinant activated factor VII. Blood Rev 2004 18 : 245 259.
12. Roberts HR, Monroe DM, White GC. The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 2004 104 : 3858 3864.
13. Franchini M, Lippi G, Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 2007 11 : 8 15.
14. Haynes J, Laffan M, Plast F. Use of recombinant activated factor VII in massive haemorrhage. Int J Obstet Anesth 2007 16 : 40 49.
15. Gowers CJD, Parr MJA. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy. Anaesth Intensive Care 2005 33 : 196 200.
16. Moscardo F, Perez F, de la Rubia J et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haemat 2001 113 : 174 176.
17. Salek SZ, Sokolic V, Viskovic T, Sanjug J, Simic M, Kastelan M. Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome. Acta Haematol 2002 108 : 162 163.
18. Sokolic V, Bukovic D, Fures R et al. Recombinant factor VIIa (rFVIIa) is effective at massive bleeding after caesarean section - A case report. Coll Antropol 2002 26 : 155 157.
19. Segal S, Shemesh IY, Blumenthal R et al. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynecol Obstet 2003 268 : 266 267.
20. Dutton RP, Hess JR, Scalea TM. Recombinant factor VIIa for control of hemorrhage: Early experience in critically III trauma patients. J Clin Anesth 2003 15 : 184 188.
21. Bouwmeester FW, Jonkhoff AR, Verheijen RH, van Geijn HP. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 2003 101 : 1174 1176.
22. Boehlen F, Morales MA, Fontana P, Ricou B, Irion O, de Moerloose P. Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: Case report and review of the literature. BJOG 2004 111 : 284 287.
23. Merchant SH, Mathew P, Vanderjagt TJ, Howdieshell TR, Crookston KP. Recombinant factor VIIa in management of spontaneous liver hematoma associated with pregnancy. Obstet Gynecol 2004 103 : 1055 1058.
24. Dart BW IV., Cockerham WT, Torres C, Kipkasa JH, Maxwell RA. A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome. J Trauma 2004 57 : 171 174.
25. Mayo A, Misgav M, Kluger Y et al. Recombinant activated factor VII (NovoSeven): Addition to replacement therapy in acute, uncontrolled and life-threatening bleeding. Vox Sang 2004 87 : 34 40.
26. Segal S, Shemesh I, Blumental R et al. The use of recombinant factor VIIa in severe postpartum hemorrhage. Acta Obstet Gynecol Scand 2004 83 : 771 772.
27. Lim Y, Loo CC, Chia V, Fun W. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. Int J Gynecol Obstet 2004 87 : 178 179.
28. Gidri M, Noble W, Rafique K, Patil K, Lindow W. Caesarean section for placenta praevia complicated by postpartum haemorrhage managed successfully with recombinant activated human coagulation Factor VIIa. J Obstet Gynecol 2004 24 : 925 926.
29. Tanchev S, Platikanov V, Karadimov D. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period. Acta Obstet Gynecol Scand 2005 84 : 402 403.
30. Gowers CJD, Parr MJA. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponse to conventional therapy. Anaesth Intensive Care 2005 33 : 196 200.
31. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br J Anaesth 2005 94 : 592 595.
32. Shamsi TS, Hossain N, Soomro N et al. Use of recombinant factor VIIa for massive postpartum haemorrhage: Case series and review of literature. J Pak Med Assoc 2005 55 : 512 515.
33. Hollnberger H, Gruber E, Seelbach-Goebel B. Major post-partum hemorrhage and treatment with recombinant factor VIIa. Anesth Analg 2005 101 : 1886 1887.
34. Biss TT, Hanley JP. Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: Use of a clinical scoring system to predict outcome. Vox Sang 2006 90 : 45 52.
35. Verre M, Bossio F, Mammone A, Piccirillo M, Tancioni F, Varano M. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage. Minerva Ginecol 2006 58 : 81 84.
36. Palomino MAP, Chaparro MJS, de Elvira MJZR, Curiel EB. Recombinant activated factor VII in the management of massive obstetric bleeding. Blood Coagul Fibrinolysis 2006 17 : 226 227.
37. Heilmann L, Wild C, Honjnacki B, Pollow K. Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII. Clin Appl Thromb Hemost 2006 12 : 227 229.
38. Hamaekers AEW, von Mook WNKA, Offermans JPM, Marcus MAE. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage. Am J Crit Care 2006 15 : 399 401.
39. Pepas LP, Arif-Adib M, Kadir RA. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. Obstet Gynecol 2006 108 : 757 761.
40. Haynes J, Laffan M, Plaat F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth 2007 16 : 40 49.
41. Prosper SC, Goudge CS, Lupo VR. Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. Obstet Gynecol 2007 109 : 524 545.
42. Spahn DR, Tucci MA. Is recombinant FVIIa the magic bullet in the treatment of major bleeding? Br J Anaesth 2005 94 : 553 555.
43. Sobieszczyk S, Breborowicz GH, Platicanov V, Tanchev S, Kessler CM. Recombinant factor VIIa in the management of postpartum bleeds: An audit of clinical use. Acta Obstet Gynecol Scand 85 : 1239 1247.
44. Karalapillai D, Popham P. Recombinant factor VIIa in massive postpartum haemorrhage. Int J Obstet Anesth 2007 16 : 29 34.
45. Franchini M, Manzato F, Salvagno GL, Lippi G. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: A systematic review. Blood Coagul Fibrinolysis 2007 18 : 589 593.
46. Hoffman M, Monroe DM. A cell-based model of haemostasis. Thromb Haemost 2001 85 : 958 965.
47. Banninger H, Lammle B, Furlan M. Binding of alpha-thrombin to fibrin depends on the quality of the fibrin network. Biochem J 1994 298 : 157 163.
48. Aledort L. rFVIIa: Its thrombogenicity. Thromb Haemost 2000 84 : 522 523.
49. Roberts H. Clinical experience with activated factor VII: Focus on safety aspects. Blood Coagul Fibrinolysis 1998 9 : S115 S118.